DOI: 10.2217/fon-2021-0923

Paper Summary:

Title: MARIPOSA: phase 3 study of first-line amivantamab + lazertinib versus osimertinib in EGFR-mutant non-small-cell lung cancer

Author(s): Cho, Byoung Chul (author);Felip, Enriqueta (author);Hayashi, Hidetoshi (author);Thomas, Michael (author);Lu, Shun (author);Besse, Benjamin (author);Sun, Tao (author);Martinez, Melissa (author);Sethi, Seema N (author);Shreeve, S Martin (author);Spira, Alexander I (author)

Year: 2022

DOI: 10.2217/fon-2021-0923

URL: https://doi.org/10.2217/fon-2021-0923

Download Paper from Sci-Hub:

Generate Citation

✍: FYIcenter.com

2024-06-08, ∼691👍, 0💬